Clinical Trial Update: A Study to Investigate Vamikibart (RO7200220) in Combination With Ranibizumab in Diabetic Macular Edema [Phase 2]

View source ↗

Summary

Phase 2 study evaluating Vamikibart in combination with Ranibizumab for diabetic macular edema has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Ranibizumab (ranibizumab)
• Vamikibart (RO7200220)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Diabetic Macular Edema | Phase 2 | Status: COMPLETED | Results posted: 2025-10-16